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ABSTRACT
Objective: The aim was to study the antiparkinson activity in the seed extracts of four species of Mucuna.
Methods: The hydroalcoholic extracts of seeds of four species of Mucuna were evaluated for antiparkinson activity of after a preliminary phytochemical 
study. The activity was measured in rats by indirectly measuring the decrease in malondialdehyde level, decrease in tongue protrusion frequency, and 
reduction in vacuous chewing movement after administering reserpine at the dose of 1 mg/kg. The dose levels of four species of Mucuna seed extract 
were kept at 100, 200, and 300 mg/Kg.
Results: Extracts exhibited potent antiparkinson activity and achieved statistically significant p values compared with control group. The study 
corroborates and compares all four species of Mucuna.
Conclusion: Among the extracts, the highest percentage of antiparkinson activity was recorded for Mucuna pruriens.
Keywords: Mucuna pruriens, Cochinchinesis, Utilis, Deeringiana, Antiparkinson activity.
INTRODUCTION
Parkinson’s disease belongs to a group of conditions called movement 
disorders. It is characterized by muscle rigidity, tremor, a slowing 
of physical movement (bradykinesia) and in extreme cases, a loss of 
physical movement (akinesia) [1]. It is a clinical syndrome characterized 
by lesions in the basal ganglia, predominantly in the substantia 
nigra [2]. As a rule, PD begins between the ages of 40 and 70 years, 
with peak age onset in the seventh decade. The prevalence of PD is 
approximately 160 cases per 100,000 populations, and the incidence is 
about 20 cases per 100,000 populations. The pathological changes of PD 
may appear as early as three decades before the appearance of clinical 
signs [3]. The cause of PD is probably multifactorial, with contributions 
from hereditary predisposition, environmental toxins, and aging [4]. 
The most widely used form of treatment is L-DOPA in various forms. 
L-DOPA is transferred into dopamine in the dopaminergic neurons by 
L-aromatic amino acid decarboxylase.
Mucuna pruriens(L.) DC., the velvet bean, is one of the important herbal 
drugs in the Indian Systems of Medicine. Seeds of this plant contain a 
high amount of L-DOPA [5]. The seeds are used in the treatment of many 
common ailments and also as a food. The seeds have been sold in the 
herbal drug market in many parts of India in the name of “atmagupta” 
or “poonaikali” [6]. In our survey, we found that seeds of many other 
species other than M. pruriens are sold as “poonaikali” in Tamil Nadu 
and “atmagupta” or “kawanch” in other states of India. It is frightening 
to note that the crude drug traders and traditional physicians and 
pharmaceutical manufacturers, who use this seed for preparation of 
medicine, are unaware of its identity and its adulterants. As “poonaikali” 
is a common drug and big demand in India and abroad, it is essential to 
standardize the scientific lines for identifying the authentic drug and 
to detect the adulterants. Although many pharmacological works on 
seeds of M. pruriens have been carried out, comparative scientific work 
of M. pruriens and its adulterants is not available.
The seeds of M. pruriens are reported to have antiparkinson activity 
along with other activities. Commonly M. pruriens is adulterated 
with other species of the genus such as Mucuna deeringiana, Mucuna 
utilis, and Mucuna cochinchinesis. This department has worked on 
seeds of Mucuna and its adulterants on the basic phytochemical and 
pharmacological works [7]. In this work, we would study comparative 
and detailed phytochemistry and pharmacology of the seeds of 
M. pruriens and its adulterants.
MATERIALS AND METHODS
Collection of seed samples
Seeds of “poonaikali” (minimum 2 kg) were procured from different 
herbal drug stores in Madurai, Thanjavur, and Chennai. Some of the seed 
samples were collected from the Herbal Garden of Tamil University.
Preparation of extract
The collected seed samples were dried in the open sunlight for 
2 days. Then, the dried seeds were cleaned. Foreign matter, broken 
seeds, and immature seeds were removed from the sample. The 
seeds were stored in a suitable plastic container and kept at room 
temperature. Then, the seeds were powdered mechanically to 60 
mesh size. The seed powder was soaked in 70% ethanol for 72 h 
with occasional shaking. The solvent was decanted and filtered. The 
marc was subjected to further extraction by repeating the procedure 
thrice. The solvent was removed by distillation under vacuum. 
Previous work on the seeds of Mucuna species [7] had revealed 
the presence of most of the active principles in alcoholic and water 
extracts. Hence, hydroalcoholic extract was chosen for the analytical 
and pharmacological study.
Powder analysis
Behavior of seed powder with different chemical reagents was carried out 
as mentioned by Kay L [8] Johnson [9] and Birch and Doughty [10].
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Qualitative phytochemical studies
Qualitative phytochemical analysis was done using the procedure of 
Kokate (1994). Alkaloids, carbohydrates, tannins and phenols, fixed oils 
and fats, saponins and gums, and mucilages were qualitatively analyzed.
Quantitative phytochemical studies
The estimation of total alkaloid was performed by gravimetric 
method [11] total protein [12], total tannins [13], and total phenolic 
content [14].
Thin layer chromatography (TLC) studies
Extracts mixed with 0.1N HCl were spotted on silica gel G coated plates. 
N-Butanol, glacial acetic acid, and water in the ratio of 2:1:1 was used as 
mobile phase. Freshly prepared mixture of an equal proportion of 10% 
ferric chloride and 5% potassium ferricyanide was used as detecting 
agent.
One study was carried out using the above procedure with M. pruriens 
powder and a marketed pharmaceutical product containing Mucuna.
Another study was carried out with four types of extract as four spots 




Recently, a promising animal model of tardive dyskinesia has been 
proposed: The increase in tongue-protrusion frequency induced by 
repeated administration of reserpine (RE) in rats [17]. In this regard, 
although RE is not classified as a neuroleptic, it was used as an 
antipsychotic agent and has been associated with the development 
of tardive dyskinesia [18]. This RE-induced oral dyskinesia in rats 
has several other features that are consistent with this movement 
disorder, including persistence following interrupted administration, 
and a reported dose-dependent blockade induced by a D2 selective 
antagonist. As with tardive dyskinesia, RE-induced oral dyskinesia is 
exacerbated by dopamine agonists like amphetamine [19].
Furthermore, despite the fact that RE-induced tongue-protrusion 
dyskinesia in rats develops very rapidly (few days) after high 
doses [20]; this fact offers an outstanding methodological advantage 
over other proposed rodent models of tardive dyskinesia.
An important hypothesis recently receiving considerable interest is 
the proposal that the symptoms of Parkinsonism are due to neurotoxic 
effects of free radical byproducts from dopamine (DA) metabolism. 
The increase in DA turnover is produced from blockage of dopamine 
receptors by neuroleptics [21]. Dopamine undergoes monoamine 
oxidase-catalyzed oxidative deamination to 3,4-dihydroxyphenyl-
acetaldehyde (DOPAL), which is metabolized primarily to 
3,4-dihydroxyphenylacetic acid. DOPAL is a reactive radical and toxic 
to dopaminergic cells [22]. DOPAL injection into the substantia nigra of 
rats resulted in DA neuron loss [23].
There were 84 male albino mice weighing 20–40 g housed under 
conditions of controlled temperature (20±2°C) and lighting (12 h 
light/12 h dark, lights on at 7:00 am). Food and water were available 
ad libitum throughout the experiment. The mice were brought to the 
experimental laboratory 7 days before the beginning of the experiment 
and immediately housed at random in groups of 6 animals per cage. 
All procedures involving laboratory animal use were in accordance to 
the Institute Animal Ethics Committee regulations approved by the 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA).
Drugs
The drugs used in these experiments were obtained from Sigma (St. 
Louis, MO). RE was dissolved in 50 µl of glacial acetic acid and then 
diluted to the correct concentration with distilled water, and injected at 
the dose of 1 mg/kg. Vehicle consisted of the same amount of acetic acid 
and water used in the RE solution. Hydroalcoholic extract of M. pruriens 
was dissolved in 1% tween 80.
Experimental procedures
Mice were randomly divided into 14 groups of six animals each, which 
received a hydroalcoholic extract of Mucuna species at the dose of 100, 
200, and 300 mg/kg orally for the period of 16 days. On days 14 and 16, 
1 mg/kg i.p. RE was injected 1 h after the drug and vehicle treatment. 
After 24 h of the last RE injection, all the animals were subjected to 
behavioral observation as follows:
Animal behavior was initially observed in a glass cage. Mirrors were 
placed under the floor and behind the back wall of the cage to permit 
observation of oral movements when the animal faced away from the 
observer. In this experimental stage, oral movement and tremor were 
observed. The frequency of tongue protrusion and vacuous chewing 
movements (VCM) was determined using hand-operated counters. 
In the present study, tongue protrusion was operationally defined 
as a visible extension of the tongue outside of the mouth and not 
directed at anything. Individual tongue protrusions during a short 
time of oral dyskinesia were each preceded by visible retraction of 
the tongue [19]. If tongue protrusions occurred during a period of 
grooming, they were not taken into account. The incidence of tongue 
protrusions was measured continuously for 10 min. VCMs were 
scored during 5 min observation period, according to a five-point 
scale (0=absent, 1=minimal, 2=mild, 3=moderate, and 4=severe). 
A VCM consisted of a rapid movement of the jaw which resembles 
chewing but did not appear to be directed at any particular 
stimulus [24].
Stopwatches were used to quantify the duration of generalized body 
tremor, expressed in seconds. These parameters were measured 
continuously for 15 min.
The animal’s forepaws were then placed on a horizontal glass bar 
(2 mm diameter) elevated 4.5 cm above the observation floor, and the 
time elapsing before the animal removed its forepaws from the bar 
and placed them on the floor was measured. This test was repeated 
3 times during a session, with the longest elapsed time representing 
the catalepsy score, expressed in seconds [25].
Statistical analysis
Statistical analysis was performed with GraphPad Prism 5 Software 
(GraphPad Prism Software Inc. San Diego, California, USA). VCMs and 
tongue protrusions are considered to be nonparametric. Thus, the data 
were analyzed by Kruskal–Wallis analysis of variance followed by the 
Dunn’s Multiple Comparisons test. Tremor and catalepsy are considered 
to be parametric, and the data were analyzed by ANOVA followed by the 
Tukey test. A probability of p<0.05 was considered to show significant 
differences for all comparisons made.
RESULTS
Morphology of seeds
Seeds of different samples of Mucuna spp. were purchased from 
different places of Tamil Nadu such as Madurai, Thanjavur, and 
Chennai. Botanical identity of the samples was established based on the 
morphology of the seeds (plates 1–4).
Morphological description and dimensions of seeds of different samples 
are given in Table 1 (plates 1–4). Color of the seeds, weight/100 seeds, 
dimensions of seeds, thickness of seed coat, dimensions of raphae, 
thickness of cotyledon, and loss on drying were noted (Fig. 1).
The seeds of M. pruriens and its adulterants could be distinguished 
by their size and shape. Thus seeds of M. pruriens, M. cochinchinensis, 
and M. deeringiana are oval in shape and smooth and glossy. Seeds of 
M. utilis are angular in shape and smooth and glossy. On the basis of the 
dimensions, the seeds of mucuna species could be grouped as medium 
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and small. M. deeringinana and M. utilis are medium in size followed by 
M. cochinchinensis. Among all the seed samples, M. pruriens seeds are 
the smallest.
Weight of 100 seeds of the four samples has correlation to their size 
class. Thus, among the medium-sized class seeds (M. deeringiana 
and M. utilis), M. deeringiana has the highest weight. Even though 
M. cochinchinensis is smaller in size the weight of 100 seeds is slightly 
higher in proportion. M. pruriens seeds have lowest weight/100 seeds, 
among all the samples (Table 1).
Analytical values
Analytical values such as total ash, acid insoluble ash, acid soluble 
ash, and solubility percentage in water for all the four samples were 
analyzed, and their values are tabulated in Table 2. Total ash value is 
more or less same in all seed samples. M. utilis has slightly higher ash 
value. Acid-insoluble ash value is the highest (0.1222) in M. utilis and is 
lowest in M. deeringiana (0.0588%), medium values in M. pruriens, and 
M. cochinchinensis were noted. Value of solubility percentage in water 
was higher for M. pruriens seeds.
Qualitative phytochemical studies
Qualitative phytochemical analysis for alkaloids, carbohydrates 
tannins, phenols, gums and mucilage, fixed oils and fats, saponins and 
steroids was screened in four types of seed samples and was recorded 
in Table 4. Extractive values in solvents yielded distinct values for 
the four seed samples. M. deeringiana and M. utilis did not have any 
extractive value in pet ether. All the seed samples had higher extractive 
values in water followed by an alcohol. Lower values were observed for 
all the samples in chloroform. The order of extractive values in alcohol 
is MD>MU>MC>MP; and in water MU>MC>MP>MD; and in benzene 
MD>MU>MC>MP (Table 3).
Alkaloids
Presence of alkaloids was noted in all the seed samples in benzene, 
chloroform, alcohol, and aqueous extracts. Out of the four extracts, 
aqueous extracts of the samples gave more amounts of alkaloids 
followed by benzene extracts.
Preparation of hydroalcoholic extract
The collected seed samples were thoroughly shade dried for 2 days. 
Then, the dried seeds were cleaned and any foreign matter, broken 
seeds and immature seeds were removed. The seeds were stored in a 
plastic container at room temperature. Then, the seeds were powdered 
separately in a mechanical way to 60 mesh size. The seed powder was 
soaked in 70% ethanol for 72 h with occasional shaking. The solvent 
was decanted and filtered. The marc was subjected to further extraction 
by repeating the procedure thrice. The solvent was removed from the 
extract by vacuum distillation.
Quantitative phytochemical studies
Estimation of protein, carbohydrate, and alkaloids
Total protein, carbohydrate, and alkaloids in seeds of M. pruriens and 
its adulterants were estimated. Highest protein content (32%) was 
obtained in dried samples of M. pruriens followed by M. utilis (28%). 
Lowest protein content (25%) was observed in M. cochinchinensis 
seeds.
Maximum carbohydrates content (53%) was observed in M. deeringiana 
followed by M. pruriens (41%). In M. utilis lowest carbohydrate (40%) 
was observed.
Total alkaloids of seed samples reveal highest content (0.82%) in M. utilis. 
Alkaloid content in seeds is in the following order: MU>MP>MD>MC.
Phenols and tannin are present in seeds of M. pruriens, and its 
adulterants were estimated (Table 5). Highest phenol content (6.63%) 
was observed in M. utilis. M. cochinchinensis showed lowest (2.13%) 
phenol content and M. pruriens seeds had 2.15%.
Estimation of tannins in seeds showed the highest value (2.1%) in 
M. deeringiana. M. pruriens had 0.3% of tannins.
Table 1: Macroscopic details of seeds of M. pruriens and its adulterants
S. No Parameters M. pruriens M. cochinchinensis M. deeringinana M. utilis
1 Color Black Dull white Black Grey with black spots
2 Weight/100 seeds (gm) 32.72 90.64 162.14 122.36
3 Dimensions of seed 
L×B × T (mm)
12×9 × 6 14×10×7 16×11×8 15×11×8
4 Thickness of seed coat (mm) 0.20 0.25 0.17 0.12
5 Dimensions of raphae LxB 5×2 7×2 6×2 7×3
6 Thickness of cotyledon (mm) 5.32 6.08 7.61 7.64
7 LOD (%) 5.71 7.13 3.54 10.28
M. pruriens: Mucuna pruriens, M. cochinchinensis: Mucuna cochinchinensis, M. deeringinana: Mucuna deeringinana, M. utilis: Mucuna utilis
Table 2: Analytical values (in percentage) of seed powders
S. No Parameters M. pruriens M. cochinchinensis M. deeringinana M. utilis
1 Total ash value 3.2732 3.0728 3.0553 3.2908
2 Acid-insoluble ash value 0.0854 0.1231 0.0588 0.1222
3 Acid soluble ash value 3.1878 2.9497 2.9965 3.1686
4 Solubility percentage in alcohol 3.0000 2.9600 6.9200 5.7600
5 Solubility percentage in water 25.5300 21.2900 19.4700 18.500
M. pruriens: Mucuna pruriens, M. cochinchinensis: Mucuna cochinchinensis, M. deeringinana: Mucuna deeringinana, M. utilis: Mucuna utilis
Table 3: Successive extractive values of seeds in percentage
S. No. Name of the samples Benzene Pet ether Chloroform Alcohol Water
1 M. pruriens 1.932 0.014 0.106 0.857 10.059
2 M. cochinchinesis 2.634 0.354 0.226 1.697 11.021
3 M. deeringiana 5.086 - 0.569 17.354 7.499
4 M. utilis 4.269 - 1.011 5.856 12.555
M. pruriens: Mucuna pruriens, M. cochinchinensis: Mucuna cochinchinensis, M. deeringinana: Mucuna deeringinana, M. utilis: Mucuna utilis
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TLC
Coenzyme Q10 by TLC
Hydroalcoholic extracts of all the four species were spotted and 
compared with the coenzyme Q10 as the fifth spot in two solvent 
systems dioxane: water (50:50) and chloroform: methanol (55:45). 
Spots in the four extracts and the standard confirmed the presence 
of coenzyme Q10 at 254 nm 366 nm and after color development. The 
hydroalcoholic extract was dissolved in chloroform, and it is used for 
TLC analysis. The solvent systems used were dioxane: water (50:50) 
and chloroform: methanol (55:45). The spraying reagent used was 5% 
phosphomolybdic acid in ethanol. The developed blue colored spots 
were visualized after spraying 5% phosphomolybdic acid in ethanol.
Antiparkinson activity
Antiparkinson activity is measured indirectly by the following activity:
1. Decrease in malondialdehyde (MDA) level
2. Decrease in tongue protrusion frequency (TPF) and
3. Decrease in VCM.
The effect of hydroalcoholic extracts of MC, MD, MP, and MU was 
observed in the above activity and data recorded (Figs. 2-4).
Free oxygen radicals can induce lipid peroxidation in cells; MDA is 
formed during oxidative degeneration and accepted as an indicator 
of lipid peroxidation. RE increased the level of lipid peroxide, MDA, 
from 1.2±0.1125 to 2.5±0.175 (µmol/g tissue). MP and MD at the dose 
of 300 mg/kg prevented the RE-induced elevation in MDA levels and 
significantly (p<0.01) decreased its elevated levels to 1.4±0.1025 and 
1.5±0.0875 respectively (Fig. 2), when compared with disease control 
group. MU treated group does not produce a significant change in MDA 
levels when compared with RE alone treated group.
Extracts of MC, MD, MP, and MU were administered at three different 
dosages (100, 200, and 300 mg/Kg) and TPF was observed (Fig. 3). It 
was noted that TPF was increased three-fold in the control group. There 
was a dose-dependent response for all the four extracts in decreasing 
the TPF. TPF was significantly reduced by an extract of MC, MD,and MU 
and more significantly reduced by MP at the dose of 300 mg/Kg.
Effect of hydroalcoholic extract of MC, MD, MP, and MU on VCM 
frequency is shown in Fig. 4. Animals that received RE exhibited an 
Table 4: Qualitative phytochemical screening of hydroalcoholic extracts of seeds
Alkaloids Reagent/test M. pruriens M. cochinchinensis M. deeringinana M. utilis
Mayer’s reagent + + + +
Dragendorff’s reagent + + + +
Hager’s reagent + − − −
Wagner’s reagent + − + −
Mayer’s reagent + + + +
Dragendorff’s reagent + + + +
Hager’s reagent + + + +
Wagner’s reagent + + + +
Carbohydrate Molisch’s reagent + + + +
Fehling’s reagent − − − −
Benedict’s reagent + + + +
Tannins and phenols Ferric chloride + + + +
Gelatin Solution + - + +
Lead acetate + + + +
Gums and mucilage Precipitation test + + + +
Fixed oils and fats Paper pressing + + + +
Saponins Foam Test + + + +
Steroids Lieberman’s test − − − −
+: Presence, −: Absence. M. pruriens: Mucuna pruriens, M. cochinchinensis: Mucuna cochinchinensis, M. deeringinana: Mucuna deeringinana, M. utilis: Mucuna utilis
Table 5: Quantitative estimation of protein, carbohydrate, alkaloids, phenols, and tannins
S. No Name of the samples Protein (%) Carbohydrate (%) Alkaloids (%) Phenols (%) Tannin (%)
1 M. pruriens 32 41 0.48 2.15 0.3
2 M. cochinchinesis 25 41 0.13 2.13 0.6
3 M. deeringiana 27 53 0.45 5.31 2.1
4 M. utilis 28 40 0.82 6.63 1.3
M. pruriens: Mucuna pruriens, M. cochinchinensis: Mucuna cochinchinensis, M. deeringinana: Mucuna deeringinana, M. utilis: Mucuna utilis
Fig. 1: Morphology of seeds. (a) Seeds of Mucuna pruriens, 
(b) seeds of Mucuna cochinchinensis, (c) seeds of Mucuna 
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increase in VCMs compared to vehicle-treated animals (p<0.01). All 
the Mucuna species except MU produced dose-dependent effect. MC, 
MD, and MP at the dose of 200 mg/kg showed less significant (p<0.01) 
decrease in VCM, when compared with diseased control, whereas MU at 
the dose of 300 mg/kg showed significant (p<0.05) reduction in VCM, 
when compared with RE alone treated group.
DISCUSSION
The macroscopic study of the M. pruriens and the adulterants shows 
the difference in size, color, and weight. The phytochemical study 
reveals the presence of alkaloids, carbohydrate, tannins, Phenols, 
gums, mucilages, fixed oils, and saponins. The high-performance TLC 
was carried out after dissolving extracts in 0.1 m hydrochloric acid in 
methanol. The four species were kept as 1–4 tracks and the 5th track 
was standard L-DOPA.
The last track is of the reference standard L-DOPA showing a single 
peak at the Rf value of same 0.43. This confirms the presence of L-DOPA 
in all varieties and the only difference in the quantification.
RE interferes with the storage of dopamine (and also of noradrenaline 
and 5-hydroxytryptamine) in synaptic vesicles, leading to depletion 
of dopamine in nerve terminals. Its central action produces sedation, 
hypokinesia, rigidity (catalepsy), and often tremor [26,27]. The effect 
of RE on spontaneous locomotor activity is frequently used as a model 
of the motor disturbance of Parkinson’s disease [28-30] and several 
clinically used antiparkinson drugs (e.g., dopamine receptor agonists, 
L-DOPA + benserazide, amantadine, and trihexyphenidyl) have been 
shown to improve this motor impairment [30]. This suggests that the 
RE model showed good face and predictive validity [31]. M. pruriens 
increased brain dopamine level [32]. Fachinetto and colleagues [33] 
have reported that animals with VCMs have significantly higher lipid 
peroxide expressed as thiobarbituric acid reactive substances in the 
striatum, suggesting increased lipid peroxidation, and free radical 
production in these animals.
Another source of neuronal oxidative damage is related to calcium 
overload. It was hypothesized that prolonged stimulation of N-methyl-
D-aspartate (NMDA) and glutamate receptors can induce massive cell 
death in the brain (excitotoxicity), by causing calcium overload in post-
synaptic neurons [34]. Hernández-Fonseca et al. [35] have reported that 
calcium influx through NMDA receptors is involved in reactive oxygen 
species (ROS) production and neuronal damage. Lipid peroxidation is 
considered as a major mechanism of oxygen radical toxicity, thereby 
altering membrane permeability. Persistent activation of NMDA and 
non-NMDA glutamate ionotropic receptors mediates calcium entry 
and ROS production which is well-recognized perpetrators of neuronal 
oxidative damage [36]. Calcium channel blockers also prevent calcium-
overload in ischemic rat brains through their effect on the L-type 
calcium channel leading to suppression of formation of oxygen-derived 
free radicals and lipid peroxidation [37]. Our results show that Mucuna 
species markedly reduced the elevated lipid peroxide levels, MDA, that 
Fig. 2: Effect of extracts of MC, MD, MP, and MU on malondialdehyde. The values are in mean±standard error of the mean, n=6, *p<0.05 and 
**p<0.01 compared with disease control group
Fig. 3: Effect of extracts of MC, MD, MP, and MU on tongue 
protrusion frequency. The values are in mean±standard error 
of the mean, n=6, *p<0.05 and **p<0.01 compared with disease 
control group. ++p<0.01 compared with normal control group
Fig. 4: Effect of extracts of MC, MD, MP, and MU on vacuous 
chewing movement. The values are in mean±standard error of 
the mean, n=6, *p<0.05 and **p<0.01 compared with disease 
control group
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were augmented after RE treatment. The elevated MDA level is better 
reduced by M. pruriens extract when the second highest activity goes 
to M. deeringiana. M. utilis is getting third place, and M. cochinchinensis 
is in the last. This amelioration in oxidative stress parameters was 
accompanied by a moderate reduction in behavioral abnormalities such 
as VCM and TPF.
RE induced tongue protrusions to seem to be a better model of 
tardive dyskinesia. Indeed, acute dystonia frequently develops 
after the first dose of neuroleptic, whereas RE produces a decrease 
in tongue protrusion in animals observed 6 h after the first 
injection (Neisewander et al., 1994, 1996). The increase in tongue 
protrusion, however, is not observed until 24 h after the second RE 
injection or 72 h after a single injection [37]. In addition, Sussman 
et al. demonstrated that RE-induced spontaneous oral dyskinesia 
(i.e., spontaneous increase in TPF) persisted above control level for 
at least 84 days post-treatment, despite depletion of dopamine in the 
caudate putamen. These findings suggest that tongue protrusion is 
not an acute RE-elicited effect, but rather spontaneous oral dyskinesia 
that develops as a result of a persistent neuropathological change. In 
our study, the TPF is much lowered by M. pruriens extract at the dose 
of 300 mg/kg. M. deeringiana and M. cochinchinensis are having nearly 
equal effect in reducing TPF. M. utilis is comparatively less effective in 
the minimization of TPF. The reduction of VCM is highest in M. pruriens 
extract, and M. deeringiana and M. utilis are also having remarkable 
effect. M. cochinchinensis is showing poor performance in bringing 
down VCM. The content of L-DOPA and neuroprotective antioxidants 
is more in M. pruriens and M. utilis. The level of significance of 
reduction of VCM is higher in these two samples. This confirms the 
L-DOPA content plays a major role in the treatment of Parkinsonism 
and the antioxidants complement the activity.
CONCLUSION
From the present investigation, it is concluded that out of four samples 
of “Poonaikali,” M. pruriens is the authentic and effective drug. Although 
M. cochinchinensis, M. deeringiana, and M. utilis are adulterants, they 
could be used as substitutes for M. pruriens. M. pruriens is the authentic 
and effective drug in the treatment of Parkinson’s disease. The L-DOPA 
content is more in M. pruriens. Further clinical trial is needed to support 
this conclusion. As on offshoot of this work, an activity guided fraction 
of M. pruriens seeds, isolations, purification, and characterization of 
compounds in the extracts could be carried out for future work.
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